The Gastrointestinal Experimental Model Systems (GEMS) Core
胃肠实验模型系统 (GEMS) 核心
基本信息
- 批准号:10117232
- 负责人:
- 金额:$ 17.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-03-01 至 2023-02-28
- 项目状态:已结题
- 来源:
- 关键词:3-DimensionalAdvisory CommitteesAnimalsBarrett EsophagusBiological ModelsBiologyCancer PatientCell Culture TechniquesCellsClinicalCollectionColonic AdenomaColorectal CancerConsultationsCulture MediaDerivation procedureDevelopmentDifferentiation and GrowthDigestive System DisordersDiseaseEducation and OutreachExperimental ModelsGenerationsGerm-FreeGnotobioticGoalsHealthHospitalsHumanImmigrantImmunodeficient MouseInflammatory Bowel DiseasesInstitutional Review BoardsInstructionInsuranceIntestinesMaintenanceMedical centerMedicineModelingMusOrganoidsPatientsPediatricsPhysiologyPrivatizationProductionProtocols documentationPublished CommentReagentRecommendationResearch PersonnelRodentSamplingServicesSpecific qualifier valueSpecimenSurveysTechnologyTexasTissue SampleTrainingUninsuredVeteransXenograft procedureanimal facilityanimal tissuebasebiobankcollegecostembryonic stem cellgastrointestinalhuman pluripotent stem cellhuman tissueimprovedinduced pluripotent stem cellmatrigelmembermonolayerneoplasticpatient populationpre-clinicalsuccesstwo-dimensional
项目摘要
Project Summary
The Gastrointestinal Experimental Model Systems (GEMS) core is a newly reorganized of the Texas
Medical Center-Digestive & Disease Center (TMC-DDC) in 2015. Based on examination of prior usage,
reviewer comments from the previous competitive renewal, and the recommendation of the external
advisory committee, the GEMS core is organized to encompass 1) an enteroid/organoid subcore and 2) a
gnotobiotic subcore. The DDC successfully obtained Baylor College of Medicine (BCM) support to establish
a gnotobiotic animal facility during the previous Project Period. This reorganization was based on the
exciting scientific developments in the field, our unique expertise, increased DDC investigator need and use
of enteroids and gnotobiotic animals in conjunction with decreased use of the physiology services offered
by the previous Integrative Biology Core. To accomplish these aims, we will provide services, including
the following:
• Human enteroids from the TMC-DDC biobank: as 3-dimensional enteroids, monolayers or transwells
• Murine enteroids from the TMC-DDC biobank
• Complete growth media or components for growth and differentiation of human and animal enteroids
• Derivation of new primary enteroids from animals or human tissue specimens
• Derivation of stably transduced enteroid lines
• Human pluripotent stem cell-derived intestinal organoids, made from embryonic stem cells or iPS
cells
• Xenograft generation of enteroids/organoids into immunodeficient mice
• Production and maintenance of germ-free rodents
• Technical services for studies involving gnotobiotic rodents
• Creation of germ-free mice de novo
• Training, outreach, and consultative services
Importantly, there is no other similar facility in the TMC or nearby in the region. This Core is highly
synergetic with the other scientific cores of the TMC-DDC. For example, extensive cooperation with Core
E (Clinical Core) facilitates the development and approval of new IRB protocols and collection/tracking of
tissue samples required to establish new human enteroid lines. Evidence of the success of this interaction
is apparent in the >120 enteroids lines that are already established and the continued accrual of new
samples targeting specific patient populations.
项目摘要
胃肠道实验模型系统(GEMS)核心是德克萨斯州的新重组
2015年医疗中心消化与疾病中心(TMC-DDC)。
审阅者的评论以前的竞争续约以及外部的建议
咨询委员会,GEMS核心组织以涵盖1)肠道/器官子核心和2)a
gnotobiotic子核。 DDC成功获得了贝勒医学院(BCM)支持以建立
上一个项目期间的gnotobiotic动物设施。这种重组是基于
该领域令人兴奋的科学发展,我们独特的专业知识,增加了DDC研究者的需求和使用
肠内和gnotobiotic动物以及提供的生理服务的使用减少
由先前的综合生物学核心。为了实现这些目标,我们将提供服务,包括
下列:
•来自TMC-DDC生物库的人类肠to虫:作为三维的肠托动物,单层或transwells
•来自TMC-DDC生物库的鼠肠to
•完整的生长培养基或人类和动物肠道差异的成分
•从动物或人体组织标本中衍生新的原代肠杆菌
•稳定翻译的肠线的推导
•由胚胎干细胞或IPS制成的人类多能干细胞源性肠道器官
细胞
•异种移植物的肠托动物/器官在免疫缺陷的小鼠中
•无菌啮齿动物的生产和维护
•涉及Gnotobiotic啮齿动物的研究技术服务
•创建从头开始的无菌老鼠
•培训,外展和咨询服务
重要的是,TMC或该地区附近没有其他类似的设施。这个核心很高
与TMC-DDC的其他科学核心协同作用。例如,与核心的广泛合作
E(临床核心)促进了新的IRB协议的开发和批准,并收集/跟踪
建立新的人类肠道线所需的组织样品。这种互动成功的证据
在已经建立的> 120个肠线中很明显,并且持续的新产品
针对特定患者人群的样本。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NOAH Freeman SHROYER其他文献
NOAH Freeman SHROYER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NOAH Freeman SHROYER', 18)}}的其他基金
Mechanisms of telomere-induced disease: Role of intestinal malabsorption, barrier dysfunction and dsybiosis.
端粒诱发疾病的机制:肠道吸收不良、屏障功能障碍和失调的作用。
- 批准号:
10454085 - 财政年份:2022
- 资助金额:
$ 17.6万 - 项目类别:
Mechanisms of telomere-induced disease: Role of intestinal malabsorption, barrier dysfunction and dsybiosis.
端粒诱发疾病的机制:肠道吸收不良、屏障功能障碍和失调的作用。
- 批准号:
10632001 - 财政年份:2022
- 资助金额:
$ 17.6万 - 项目类别:
Mechanisms of intestinal stem cell differentiation and plasticity.
肠道干细胞分化和可塑性的机制。
- 批准号:
9788430 - 财政年份:2018
- 资助金额:
$ 17.6万 - 项目类别:
KLF5 regulation of intestinal development and stem cell homeostasis.
KLF5 调节肠道发育和干细胞稳态。
- 批准号:
8486426 - 财政年份:2011
- 资助金额:
$ 17.6万 - 项目类别:
KLF5 regulation of intestinal development and stem cell homeostasis
KLF5 对肠道发育和干细胞稳态的调节
- 批准号:
8905197 - 财政年份:2011
- 资助金额:
$ 17.6万 - 项目类别:
KLF5 regulation of intestinal development and stem cell homeostasis.
KLF5 调节肠道发育和干细胞稳态。
- 批准号:
8294532 - 财政年份:2011
- 资助金额:
$ 17.6万 - 项目类别:
KLF5 regulation of intestinal development and stem cell homeostasis.
KLF5 调节肠道发育和干细胞稳态。
- 批准号:
8162496 - 财政年份:2011
- 资助金额:
$ 17.6万 - 项目类别:
相似海外基金
Acquisition of a Bruker 11.7T/16cm Preclinical Scanner for Novel MRI/MRSI Studies
采购布鲁克 11.7T/16cm 临床前扫描仪用于新型 MRI/MRSI 研究
- 批准号:
10630511 - 财政年份:2023
- 资助金额:
$ 17.6万 - 项目类别:
Tachycardia-induced Metabolic Remodeling Drives Cardiac Dysfunction
心动过速引起的代谢重塑导致心脏功能障碍
- 批准号:
10738875 - 财政年份:2023
- 资助金额:
$ 17.6万 - 项目类别:
Bridging the gap of late gestation human nephrogenesis using a non-human primate model
使用非人类灵长类动物模型弥合妊娠晚期人类肾发生的差距
- 批准号:
10347725 - 财政年份:2022
- 资助金额:
$ 17.6万 - 项目类别:
Modeling early SARS-CoV-2 pathogenesis in human lung organoids and slice cultures
在人肺类器官和切片培养物中模拟早期 SARS-CoV-2 发病机制
- 批准号:
10449059 - 财政年份:2022
- 资助金额:
$ 17.6万 - 项目类别:
Modeling early SARS-CoV-2 pathogenesis in human lung organoids and slice cultures
在人肺类器官和切片培养物中模拟早期 SARS-CoV-2 发病机制
- 批准号:
10557881 - 财政年份:2022
- 资助金额:
$ 17.6万 - 项目类别: